FDA Drug Application (206321) for SAXENDA by NOVO NORDISK INC

Back to FDA Applications sponsored by NOVO NORDISK INC

Application Number206321
Product Number001
FormSOLUTION;SUBCUTANEOUS
Dosage18MG/3ML (6MG/ML)
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameSAXENDA
Active IngredientLIRAGLUTIDE RECOMBINANT



Back to FDA Applications sponsored by NOVO NORDISK INC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.